thymopentin has been researched along with Myasthenia Gravis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, ZG; He, XT; Huang, RX; Huang, X; Liu, WB; Zhang, Y | 1 |
He, XT; Huang, RX; Huang, X; Liu, WB; Zhang, Y | 1 |
Agarwal, SS; Biswas, S; Garg, SK; Haq, W; Mathur, KB; Singh, VK | 1 |
Audhya, TK; Goldstein, G | 1 |
2 review(s) available for thymopentin and Myasthenia Gravis
Article | Year |
---|---|
Thymopentin and splenopentin as immunomodulators. Current status.
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; Child; Dermatitis; Humans; Immunologic Deficiency Syndromes; Infections; Myasthenia Gravis; Neoplasms; Neuromuscular Agents; Peptide Fragments; Thymopentin; Thymopoietins | 1998 |
Thymopoietin to thymopentin: experimental studies.
Topics: Animals; Cell Differentiation; Hormones; Humans; Immunity; Mice; Myasthenia Gravis; Neuromuscular Junction; Peptide Fragments; Synaptic Transmission; T-Lymphocytes; Thymopentin; Thymopoietins; Thymus Hormones | 1985 |
1 trial(s) available for thymopentin and Myasthenia Gravis
Article | Year |
---|---|
[Thymopentin 5 in treatment of relapse after extended thymectomy: a randomized comparative clinical trial of 135 patients with myasthenia gravis].
Topics: Adjuvants, Immunologic; Adult; Child; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myasthenia Gravis; Postoperative Period; Prospective Studies; Recurrence; Thymectomy; Thymopentin; Treatment Outcome | 2008 |
1 other study(ies) available for thymopentin and Myasthenia Gravis
Article | Year |
---|---|
[Mediation of cellular immune response by TP5 in pathogenesis of myasthenia gravis].
Topics: Adjuvants, Immunologic; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Child; Female; Humans; Interferon-gamma; Male; Myasthenia Gravis; T-Lymphocytes, Regulatory; Thymopentin | 2009 |